Page 9 - Import Alert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Feb 19, 2021 9:41am The FDA hit India's Shilpa with an import alert on all but three of its drugs after the company failed to address problems cited in an October warning letter. (Pixabay/qimono) Just a few months after India-based drugmaker Shilpa Medicare found itself in the FDA's crosshairs, the company now faces a ban on the vast majority of its products in the U.S.  The FDA slapped an import alert on Shilpa Medicare's formulation plant in Telangana, India, according to a notice posted Thursday. The product ban comes on the heels of an FDA warning letter that cited the Indian drugm...

Indian markets dip ahead of weekly expiry today, Nifty slips below 15200 while Sensex tests 51300. Nifty Bank underperforms benchmark indices, down over 1% in trade. PSE Index rallies most since April 30, 2020.

Read more about US FDA Import Alert takes its toll on Shilpa Medicare on Business Standard. Shilpa Medicare slumped 10.88% to Rs 380.25 after the company received an Import Alert from the United States Food and Drug Administration (US FDA), pursuant to its inspection of Unit 4 of the company's Telangana facility.

Three products exempted from Import Alert Shilpa Medicare has received an Import Alert 66-40 on 17 February 2021, pursuant to the USFDA inspection of the Unit 4, Jadcherla, Telangana facility from 13 February to 20 February and 24 February to 25 February 2020. The company announced that three products have been exempted from the Import Alert - Azacitidine for Injection, Cyclophosphamide Capsules and Erlotinib Tablets Powered by Capital Market - Live News (This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) Dear Reader, Business Standard h...

Domestic indices declined for third consecutive trading session on selling pressure in index pivotals. The Nifty slipped below the 15,100 mark in intraday trade but managed to close above that level. Negative cues from Asian markets impacted sentiment. As per the provisional closing data, the barometer index, the S&P BSE Sensex, dropped 379.14 points or 0.73% at 51,324.07. The Nifty 50 index fell 89.95 points or 0.59% at 15,118.35. The broader market outperformed the benchmark indices. The S&P BSE Mid-Cap index rose 0.69% while the S&P BSE Small-Cap index gained 0.67%. The market breadth, in...